DOCSLIB.ORG

Treatment of Alcoholic Hallucinosis.] Acta Neurol Psychiatr Belg

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Treatment of Alcoholic Hallucinosis.] Acta Neurol Psychiatr Belg Treatment of alcohol-induced psychotic disorder (alcoholic hallucinosis) ANGOR UNIVERSITY Masood, Barkat; Lepping, Peter; Romanov, Dimitry; Poole, Robert Alcohol and Alcoholism DOI: 10.1093/alcalc/agx090 PRIFYSGOL BANGOR / B Published: 01/05/2018 Peer reviewed version Cyswllt i'r cyhoeddiad / Link to publication Dyfyniad o'r fersiwn a gyhoeddwyd / Citation for published version (APA): Masood, B., Lepping, P., Romanov, D., & Poole, R. (2018). Treatment of alcohol-induced psychotic disorder (alcoholic hallucinosis): A systematic review. Alcohol and Alcoholism, 53(1), 259-267. https://doi.org/10.1093/alcalc/agx090 Hawliau Cyffredinol / General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal ? Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. 02. Oct. 2021 Title: Treatment of alcohol-induced psychotic disorder (alcoholic hallucinosis) - a systematic review. Authors: Dr. Barkat Masood, Specialist Trainee 6 General Adult Psychiatry, Betsi Cadwaladr University Health Board (BCUHB), Wrexham, Wales, LL13 7TX. Email: [email protected] . Telephone 01978 726873. Prof. Peter Lepping, Consultant Psychiatrist (BCUHB), Honorary Professor (Centre for Mental Health and Society, Bangor University and Mysore Medical College and Research Institute, India). Email: [email protected] Prof. Dmitry Romanov, Consultant Psychiatrist and Professor of Psychiatry, Department of Psychiatry and Psychosomatics, I.M. Sechenov First Moscow State Medical University, Moscow, Russia; and Mental Health Research Center, Moscow, Russia). Email: [email protected] Prof. Rob Poole, Consultant Psychiatrist (BCUHB) and Professor of Social Psychiatry (Centre for Mental Health and Society), University of Bangor, Bangor, Wales. Email: [email protected] Short Summary: This systematic review of alcohol-induced psychotic disorder treatment found 15 studies and 10 case reports of relevance. Older studies of first- generation antipsychotics reported full or partial remission in most patients, as did newer studies with second-generation antipsychotics. Novel drugs reported low remission rates. Standard alcohol withdrawal treatments were successful. 1 MeSH terms / Key words: Psychoses, Alcoholic; Treatment; Treatment outcomes; Hallucinations, Verbal Auditory; Hallucinations, Organic; Review, systematic; Drug therapy; Alcoholism. Running Head: Review of alcoholic hallucinosis treatment. Word Count: 3,059 words excluding abstract. Abstract: 153 words. Declarations of Interest All authors have no declarations of interest. 2 Treatment of alcohol-induced psychotic disorder (alcoholic hallucinosis) - a systematic review. Barkat Masood, Peter Lepping, Dmitry Romanov, Rob Poole. Abstract Background Alcohol-induced psychotic disorder (AIPD) is described by ICD-10 and DSM-5. It is a condition that is distinct from schizophrenia and has a close relationship with alcohol withdrawal states. There is sparse evidence to guide treatment of AIPD. Aims To evaluate the effectiveness of evidence based treatments for AIPD. Method A systematic review using PRISMA guidelines was conducted. Results Of 6,205 abstracts found, fifteen studies and ten case reports met criteria and were examined. Larger studies examined the use of first generation antipsychotic drugs, reporting full or partial remission in most patients. Newer case reports report similar results using second generation antipsychotic drugs. Novel treatments, such as those acting on GABA receptors reported low numbers of patients in remission. Some large studies report the successful use of standard alcohol withdrawal treatments. Conclusion The findings of our systematic review are inconclusive. There was significant heterogeneity between and within studies. Significant publication bias is likely. 3 Randomised control trials of more carefully delineated samples would produce evidence of greater clinical utility, for example on differential effectiveness of antipsychotics and optimal length of standard alcohol withdrawal treatments. AIPD patients who show poor treatment responses should be studied in greater depth. 4 Background Excess alcohol consumption results in medical and social problems around the world. It accounts for 3% of global deaths (Rehm et al, 2009). Neuropsychiatric consequences to alcohol dependence syndrome include delirium tremens, alcohol- related brain damage, Korsakoff’s syndrome and alcoholic hallucinosis. The terms “alcoholic hallucinosis” and “alcohol-induced psychotic” disorder (AIPD) are often used interchangeably, although they may be better regarded as over-lapping categories. In this review we follow ICD-10 (WHO, 1992) in using the rubric AIPD to include both syndromes (ICD-10 code F10.5, corresponding to DSM-5 code 292.1). According to ICD-10 (WHO 2016 version), AIPD is a condition where mental and behavioural symptoms manifest within 2 weeks of alcohol use and must persist for more than 48 hours. Symptoms should not arise as part of alcohol intoxication or an alcohol withdrawal state. Clouding of consciousness should not be present to more than to a minor degree. An episode can persist for up to six months. A wide variety of symptoms can occur, including schizophreniform delusions, hallucinations, depression and mania. DSM-5 (APA, 2013) specifies that the substance should be capable of causing symptoms and that the condition should not be better explained by another psychotic disorder. There are a number of assertions made within the AIPD literature. In a Finnish study, AIPD was found to have a general population lifetime prevalence of 0.41%, or 4% for people with alcohol dependence syndrome. It was most common amongst men of working age (Perälä et al, 2010). AIPD is said to manifest immediately after the consumption of large amounts of alcohol. It may not be related to duration of alcohol 5 dependence syndrome (George & Chin, 1998; Perälä et al, 2010). Symptoms may develop during alcohol intoxication or withdrawal or soon thereafter. The diagnosis cannot be made until clear consciousness is restored. AIPD is said to usually resolve within 18 to 35 days with antipsychotic and/or benzodiazepine treatment (Vicente Muelas et al, 1990). A minority of patients may have persistent symptoms for six months or more (Benedetti, 1952; Bradley-Burton, 1958). AIPD may end through alcohol abstinence alone and return soon after reinstatement of drinking (Glass, 1989b). The assertion that antipsychotic drugs are the treatment of choice (Jordaan & Emsley, 2014; Soyka, 1988) is not supported by published randomised controlled trials (RCTs). A number of factors affecting people with AIPD make it difficult to recruit and retain participants in RCTs (Perälä et al, 2010). There are few rigorous published studies of treatments for AIPD. This systematic review was conducted in order to evaluate the available evidence on treatment. Methods PRISMA Guidelines were used to carry out a systematic review. Medline, EMBASE, PsychINFO, Cochrane and CINAHL databases were searched for studies that had been published between 1st January 1900 and 18th August 2016. Subject search terms were: hallucinations / or alcoholism / or psychoses / or alcoholic psychoses / or chemically induced, drug therapy, prevention & control, rehabilitation, therapy / or alcohol intoxication / or delusions / or delirium / or dissociative disorders. (Search strategy available on request.) Initial inclusion criteria for screening purposes were articles that: 6 had been published in any language, investigated alcohol with or without polysubstance misuse, investigated hallucinations, investigated hallucinations attributed to alcohol and polysubstance misuse, investigated hallucinations that persisted beyond one week of alcohol/drug withdrawal state, investigated any treatment of symptoms, investigated any outcome measures, investigated patients of any age, were RCTs, were case reports or series. There were eight exclusion criteria during the screening phase: papers that did not have abstracts (Criterion 1), non-human studies (Criterion 2), examined acute confusional states/delirium, symptoms that occurred during alcohol/drug withdrawal states of less than one week duration, delirium tremens, drug intoxication states and organic psychoses (Criterion 3), did not examine hallucinations or psychoses (Criterion 4), examined schizophrenia, bipolar disorder, mood disorder or delusional disorder (Criterion 5), did not examine alcohol related hallucinosis or examined hallucinations due to polysubstance misuse (Criterion 6), single case studies (Criterion 7) and did not examine treatment or include outcome measures (Criterion 8). 7 The minimum standard for outcome measures was classification into no remission, partial remission or full remission. RESULTS 7,347 articles were identified and 6,205 remained after duplicates were removed. Abstracts for the 6,205
Load more

Recommended publications
  • Nottinghamshire Primary Care Alcohol Misuse Guidelines
    Nottinghamshire Primary Care Alcohol Dependence Guidelines V5.2 Last reviewed: April Review date: August 2021 2022 Title Nottinghamshire Primary Care Alcohol Dependence Guidelines Version 5.2 Lead - Dr Stephen Willott, GP Windmill Practice, Nottingham; Clinical Lead for alcohol misuse, Nottingham Recovery Network and Public Health Department, Nottingham City Council Author / Tanya Behrendt, Senior Pharmacist (Nottingham City Locality), NHS Nottingham and Nottinghamshire CCG Nominated Apollos Clifton-Brown, Operational Manager, Nottingham Recovery Network Dr David Rhinds, Consultant Addictions Psychiatrist, Nottinghamshire Healthcare NHS Foundation Trust Lead Dr Kaanthan Jawahar, ST6 Old Age Psychiatry, Derbyshire Healthcare NHS Foundation Trust Hannah Godden, Mental Health Interface and Efficiencies Pharmacist, Nottinghamshire Healthcare NHS Foundation Trust/ NHS Nottingham and Nottinghamshire CCG Jill Theobald, Interface Efficiencies Pharmacist, NHS Nottingham and Nottinghamshire CCG Approval Date August 2019 Review Date August 2022 Section Contents Page Number i. Summary 2 1. Introduction 4 2. Scope 5 3. Aims of Community Detoxification 5 4. Identifying suitable patients 5 5. Medical risks of community detoxification 6 6. Risk reduction 6 7. Record keeping 7 8. Equipment 7 9. Preparation for home detoxification 7 10. Medication 8 11. Relapse prevention/Follow up 8 12. Reducing alcohol consumption in people with alcohol dependence 9 13. Potentially difficult situations 10 14. References and version control 10 Appendix A Diagnostic Criteria
    [Show full text]
  • The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines
    The ICD-10 Classification of Mental and Behavioural Disorders: Clinical descriptions and diagnostic guidelines World Health Organization F10 - F19 Mental and behavioural disorders due to psychoactive substance use Overview of this block F10. – Mental and behavioural disorders due to use of alcohol F11. – Mental and behavioural disorders due to use of opioids F12. – Mental and behavioural disorders due to use of cannabinoids F13. – Mental and behavioural disorders due to use of sedative hypnotics F14. – Mental and behavioural disorders due to use of cocaine F15. – Mental and behavioural disorders due to use of other stimulants, including caffeine F16. – Mental and behavioural disorders due to use of hallucinogens F17. – Mental and behavioural disorders due to use of tobacco F18. – Mental and behavioural disorders due to use of volatile solvents F19. – Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances Four- and five-character codes may be used to specify the clinical conditions, as follows: F1x.0 Acute intoxication .00 Uncomplicated .01 With trauma or other bodily injury .02 With other medical complications .03 With delirium .04 With perceptual distortions .05 With coma .06 With convulsions .07 Pathological intoxication F1x.1 Harmful use F1x.2 Dependence syndrome .20 Currently abstinent .21 Currently abstinent, but in a protected environment .22 Currently on a clinically supervised maintenance or replacement regime [controlled dependence] .23 Currently abstinent, but receiving treatment with
    [Show full text]
  • Alcohol Withdrawal
    Alcohol withdrawal TERMINOLOGY CLINICAL CLARIFICATION • Alcohol withdrawal may occur after cessation or reduction of heavy and prolonged alcohol use; manifestations are characterized by autonomic hyperactivity and central nervous system excitation 1, 2 • Severe symptom manifestations (eg, seizures, delirium tremens) may develop in up to 5% of patients 3 CLASSIFICATION • Based on severity ○ Minor alcohol withdrawal syndrome 4, 5 – Manifestations occur early, within the first 48 hours after last drink or decrease in consumption 6 □ Manifestations develop about 6 hours after last drink or decrease in consumption and usually peak about 24 to 36 hours; resolution occurs in 2 to 7 days 7 if withdrawal does not progress to major alcohol withdrawal syndrome 4 – Characterized by mild autonomic hyperactivity (eg, tachycardia, hypertension, diaphoresis, hyperreflexia), mild tremor, anxiety, irritability, sleep disturbances (eg, insomnia, vivid dreams), gastrointestinal symptoms (eg, anorexia, nausea, vomiting), headache, and craving alcohol 4 ○ Major alcohol withdrawal syndrome 5, 4 – Progression and worsening of withdrawal manifestations, usually after about 24 hours from the onset of initial manifestations 4 □ Manifestations often peak around 50 hours before gradual resolution or may continue to progress to severe (complicated) withdrawal, particularly without treatment 4 – Characterized by moderate to severe autonomic hyperactivity (eg, tachycardia, hypertension, diaphoresis, hyperreflexia, fever); marked tremor; pronounced anxiety, insomnia,
    [Show full text]
  • Recovery Center of America
    CERTIFICATE OF NEED APPLICATION INTERMEDIATE CARE FACILITY 4620 Melwood Road Upper Marlboro, Maryland Applicant: 4620 Melwood Road OPCO, LLC March 27, 2015 Table of Contents Page PART I - PROJECT IDENTIFICATION AND GENERAL INFORMATION ................................... 1 1. FACILITY ............................................................................................................ 1 2. NAME OF OWNER ............................................................................................. 1 3. APPLICANT ........................................................................................................ 1 4. NAME OF LICENSEE OR PROPOSED LICENSEE ........................................... 2 5. LEGAL STRUCTURE OF APPLICANT ............................................................... 2 6. PERSON(S) TO WHOM QUESTIONS REGARDING THIS APPLICATION SHOULD BE DIRECTED ............................................................ 2 7. TYPE OF PROJECT ........................................................................................... 4 8. PROJECT DESCRIPTION .................................................................................. 4 A. Executive Summary of the Project ........................................................... 4 B. Comprehensive Project Description ......................................................... 5 9. BED INVENTORY ..............................................................................................14 10. COMMUNITY BASED SERVICES .....................................................................14
    [Show full text]
  • Phenomenology Epidemiology
    Phenomenology DEFINITIONS Intoxication: reversible, substance-specific physiological and behavioral changes due to recent exposure to a psychoactive substance. Addiction: compulsion to use a drug, usually for its psychic, rather than therapeutic, effects Tolerance: the decline in potency of an opioid experienced with continued use, so that higher doses are needed to achieve the same effect. This is a receptor mediated effect, typical of many psychoactive drugs. Physical Dependence: refers to the development of withdrawal symptoms once a drug is stopped. Withdrawal: a physiological state that follows cessation or reduction in the amount of a drug used. Generally these effects are the opposite of the drugs normal effects. Substance Dependence (DSM version): A maladaptive pattern of substance use with adverse clinical consequences. Substance Abuse (DSM version): A maladaptive pattern of use that causes clinically significant impairment. Alcoholism: A repetitive, but inconsistent and sometimes unpredictable loss of control of drinking which produces symptoms of serious dysfunction or disability. Clearly there is a wide range of findings possible on the mental status exam, however any exam should look for typical signs of regular substance use. Epidemiology Use of psychoactive substances is common in society, and is often socially acceptable or at least tolerated. Historically, psychoactive substance has served a variety of purposes, including medicinal, social, recreational and religious. In the U.S., 90% people report some alcohol use, 80% report some caffeine use, 25% report use of tobacco products, and 37% report having used illicit substances (at least once in life). Dependence and Abuse are also very common (13.6% in ECA). Over 10 million Americans are alcoholics, over 8 million are "Problem drinkers." Only 3% of alcoholics are on skid row.
    [Show full text]
  • A Survey of Current Music Therapy Practices Forclients With
    Florida State University Libraries Electronic Theses, Treatises and Dissertations The Graduate School 2014 A Survey of Current Music Therapy Practices for Clients with Substance Abuse and Eating Disorders Christopher M. Beach Follow this and additional works at the FSU Digital Library. For more information, please contact [email protected] FLORIDA STATE UNIVERSITY COLLEGE OF MUSIC A SURVEY OF CURRENT MUSIC THERAPY PRACTICES FOR CLIENTS WITH SUBSTANCE ABUSE AND EATING DISORDERS By CHRISTOPHER M. BEACH A Thesis submitted to the College of Music in partial fulfillment of the requirements for the degree of Master of Music Degree Awarded: Summer Semester, 2014 © 2014 Christopher M. Beach Christopher Beach defended this thesis on June 11, 2014. The members of the supervisory committee were: Jayne Standley Professor Directing Thesis Dianne Gregory Committee Member Clifford Madsen Committee Member The Graduate School has verified and approved the above-named committee members, and certifies that the thesis has been approved in accordance with university requirements. ii I wish to dedicate this thesis to those bound by the thoughts of others. Believe in yourself and extraordinary things will happen. “I’m nothing great. But I’m a rose… I’m a rose whether I’m admired or not. I’m a rose whether anyone’s crazy about me or not… Like I said, nothing great. Just a rose… But, do you know what it means to be a rose, my friend? Being a rose means ‘freedom.’ It means not existing by the praises of others or not ceasing to exist by their disapproval.” - Serdar Özkan iii ACKNOWLEDGMENTS I would like to thank the following people: Dr.
    [Show full text]
  • Binge Drinking”
    DRINKING U. S. A. Accidents Suicides Unintentional injuries Homicide 13/liters year Alcohol consumption per person in ITALY 7.6/liters years Trend interrupted between 2001 and 2003 the average consumption per person of alcohol increased from 9.1 liters to 10.5 liters in the population (> 15yrs) since <Europe, however, the average (of 25yrs) and in our neighboring countries such as Spain, France and Germany; The Italian data is still above the level of average consumption per person that the O.M.S. recommend to the countries of the European regions for the year 2015, at 6 liters / year> 15 yrs, whereas age <15 yrs = 0 The alarming thing is for young people First drink at the age 11 years (14-15 years ?) On average 12,2 years, compared with 14,6 the European average In the age group between 11 and 24 years, 13,2% of males and 4,4% of females have practiced “binge drinking” “Binge drinking” Drugs He alone understood He had 34% exercise “Binge drinking” fallen into darkness. And the instant he knew, at least once a week he ceased to know. (compared to 28% European average) Jack London “Drunkorexia” Eating behavior disorder Substance abuse in girls (to alleviate hunger) New trend Add the lack of food Alcohol abuse “Drunkorexia” Only alcoholic beverages as food !!! -Alcoholic beverages with alcohol content of 5-6% -Inviting colors (trendy presentation) -Sweet and nice -Easy to abuse -Dependence “Happy hour” For 17.4% of teenagers this is the moment “Pubwhen they crawl” drink alcohol “Drink as much as you can” “Open Bar” males females “Pub crawl” Butellon Alcohol consumption Drug in adolescents consumption Synergistic; The one reinforces the other cocaine+alcohol = cocactilene Behavioural problems Poor school performance School abseenteism Risky sexual behavior Interference in the transition from adolescence to adulthood Tienilo a mmente chi è ‘o Tienilobbuono a mmentee chi è ‘o chi malamente…..
    [Show full text]
  • Unilateral Auditory Hallucinations in Association with Ear Infection
    IrJ Psych Med 1998; 15(3): 110-114 3. Serous5 or purulent otitis media can trigger polysensory our concern regarding the cohort of patients described by hallucinations. Gross et al, specifically their finding that "hallucination in 4. Diseased ears are oversensitive to drugs8" and alcohol general correlated 0.48 clouding of the sensorium".2 Using amplifies existing otopathic hallucinations. ICD-10' clear consciousness is required to diagnose alco­ 5. Auditory hallucinations in alcoholics arise from periph­ holic hallucinosis which comes under the rubric "alcohol eral tinnitus. induced psychotic states predominantly hallucinatory" and 6. Visual and auditory alcoholic hallucinations have it is not clear therefore that the cases considered by Gross common correlates. satisfy modern criteria for alcoholic hallucinosis as such 7. Hallucinations and some psychotic symptoms7 arise the cases cited above may not therefore be comparable to from irritation of the peripheral audiovestibular system. our individual case. The last conclusion is the most bizarre of all, but has the Regarding the second point Dr Gordon provides an considerable merit of removing the need for six other interesting alternative explanation for the genesis of visual feeble, ad hoc, or desperate counter-explanations. hallucinations in alcoholic hallucinosis citing additional case reports and references. In the case of our patient, there AG Gordon was no clinical evidence of vestibular dysfunction. The 32 Love Walk, transient early morning retching could have represented London SE5 8AD, such a symptom but had been present through much of the England. patients long 'drinking-life' and was much more likely to be a symptom of alcohol withdrawal. We cited a number References of recent references detailing neurotransmitter dysfunction 1.
    [Show full text]
  • Alcoholism and Co-Morbid Psychiatric Disorders Among American Indians
    ALCOHOLISM AND CO-MORBID PSYCHIATRIC DISORDERS AMONG AMERICAN INDIANS Joseph Westermeyer, M.D., M.P.H., Ph.D. Abstract: Much of the data reported here regarding American Indian (AI) people has originated from specific areas with particular peoples. Thus, one must be cautious in applying information from one tribe to the hundreds of tribes living across the United States. As with any people, psychiatric disorder may be a pre-existing rationale for using alcohol. Or alternatively, alcohol may lead to various psychiatric disorders, such as organic mental conditions, posttraumatic stress disorder, or other conditions. A third alternative is that both alcoholism and other psychiatric disorder merely happen to affect the same person by chance. Recognizing alcoholism and treating it in a timely manner before disabling or even permanent psychiatric disorders ensue are key strategies. In addition, clinicians must be able to recognize and then either treat or refer co-morbid patients for appropriate care. Some psychiatric disorders, such as panic disorder, posttraumatic stress disorder, and various organic mental disorders may occur more often in some AI groups. Other co-morbid conditions, such as eating disorders, may occur less often among AI patients with alcoholism. It could be argued that resources should go solely to preventive efforts, thereby negating the need for psychiatric services. However, successful prevention of alcoholism may hinge upon, and increase the need for greater psychiatric services in AI communities. Caveat American Indian (AI) people in the United States comprise over 300 federally recognized tribes. They live on 278 mostly rural reservations and in scores of towns and cities.
    [Show full text]
  • Vital and Health Statistics; Series 4, No. 6
    NATIONAL CENTER Serbs 4 For HEALTH STATISTICS INumber 6 VITAL and HEALTH STATISTICS DOCUMENTS AND COMMITTEE REPORTS Report of the UnitedStatesDelegationto the InternationalConference for the EighthRevisionof the International Classification of Diseases Geneva, Switzerland =My 6-12, 1965 Discussion and recommendations at the Conference that was concerned primarily with Eighth Revision of the International Classification of Diseases and gave some consideration to multiple-cause tabulation and analysis and to hospital sta- tistics. DHEW Publication No. (HSM) 73-1264 Washington, D .C, September 1966 U.S. DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE Public Health Service John W. Gardner William H. Stewart Secretary Surgeon General Public Health Service Publication No. 1000-Series 4-No. 6 NATIONAL CENTER FOR HEALTH STATISTICS FORREST E. LINDER, PH. D., Director THEODORE D. WOOLSEY, ~@@ ~i?’eC~Or OSWALD K. SAGEN, Pr.x.D., ~ni-rtatzt Dir#ctor WALT R. SIMMONS, M.A., statistical Advisor ALICE M; WATERHOUSE, M. D., ilfedical ~dvifor JAMES E. KELLY, D.D.S., Dental zfdvi.ror LOUIS R. STOLCIS, M.A,, Executive Ojiccr OFFICE OF HEALTH STATISTICS. ANALYSIS IWAO M. MORIYAMA, PH. D., Ckiej DIVISION OF VITAL STATISTICS ROBERT D. GROVE, PH. D., (Wej DIVISION OF HEALTH INTERVIEW STATISTICS PHXLXPS. LAWRENCE, Sc. D., (Y@ DIVISION OF HEALTH RECORDS STATISTICS MONROE G. SIRKEN, PH. D.j Chief DIVISION OF HEALTH EXAMINATION STATISTICS ARTHURJ. MCDOWELL, Chief DIVISION OF DATA PROCESSING SIDNEY BXNDEB,Chief Public Health Service Publication No. 1000-Series 4-No.
    [Show full text]
  • Substance Use Disorder Treatment for People with Co-Occurring Disorders UPDATED 2020
    Substance Use Disorder Treatment for People With Co-Occurring Disorders UPDATED 2020 TREATMENT IMPROVEMENT PROTOCOL TIP 42 This page intentionally left blank. TIP 42 Please share your thoughts about this publication by completing a brief online survey at: www.surveymonkey.com/r/KAPPFS The survey takes about 7 minutes to complete and is anonymous. Your feedback will help SAMHSA develop future products. i This page intentionally left blank. TIP 42 Contents Foreword vii Executive Summary ix Overall Key Messages ix Content Overview x Consensus Panel xvii TIP Development Participants xvii KAP Expert Panel and Federal Government Participants xviii Publication Information xxvii Chapter 1—Introduction to Substance Use Disorder Treatment for People With Co-Occurring Disorders 1 Scope of This TIP 2 Terminology in This TIP 3 Important Developments That Led to This TIP Update 6 Why Do We Need a TIP on CODs? 7 The Complex, Unstable, and Bidirectional Nature of CODs 11 Conclusion 12 Chapter 2— Guiding Principles for Working With People Who Have Co-Occurring Disorders 13 General Guiding Principles 14 Guidelines for Counselors and Other Providers 16 Guidelines for Administrators and Supervisors 21 Conclusion 29 Chapter 3—Screening and Assessment of Co-Occurring Disorders 31 Screening and Basic Assessment for CODs 32 The Complete Screening and Assessment Process 36 Considerations in Treatment Matching 65 Conclusion 68 Chapter 4—Mental and Substance-Related Disorders: Diagnostic and Cross-Cutting Topics 69 Depressive Disorders 71 Bipolar I Disorder 76 Posttraumatic
    [Show full text]
  • Pathophysiology and Treatment of Alcohol Withdrawal Syndrome: a Review
    PATHOPHYSIOLOGY AND TREATMENT OF ALCOHOL WITHDRAWAL SYNDROME: A REVIEW Dana Bartlett, BSN, MSN, MA, CSPI Dana Bartlett is a professional nurse and author. His clinical experience includes 16 years of ICU and ER experience and over 20 years of as a poison control center information specialist. Dana has published numerous CE and journal articles, written NCLEX material and textbook chapters, and done editing and reviewing for publishers such as Elsevier, Lippincott, and Thieme. He has written widely about toxicology and was recently named a contributing editor, toxicology section, for Critical Care Nurse journal. He is currently employed at the Connecticut Poison Control Center and is actively involved in lecturing and mentoring nurses, emergency medical residents and pharmacy students. ABSTRACT Alcohol withdrawal can be mild and self-limiting but patients can also suffer serious complications and death. Providing care for a patient who is going through alcohol withdrawal is very challenging. Health clinicians with specialized knowledge, including a basic understanding of the pathophysiology of the syndrome, and an ability to make judicious decisions about medication administration are best able to support patients experiencing alcohol withdrawal. Clinicians knowledgeable about alcohol use and withdrawal need to show flexibility to change their approach to patient care as the clinical condition evolves. 1 nursece4less.com nursece4less.com nursece4less.com nursece4less.com Policy Statement This activity has been planned and implemented in accordance with the policies of NurseCe4Less.com and the continuing nursing education requirements of the American Nurses Credentialing Center's Commission on Accreditation for registered nurses. It is the policy of NurseCe4Less.com to ensure objectivity, transparency, and best practice in clinical education for all continuing nursing education (CNE) activities.
    [Show full text]